|
USA
' << ... "They said, 'We'll
license you the molecule, and you can buy it, repackage it,
do whatever you want. Or you can build your own plant.' ''
said Jeffrey Peck, an analyst at Bear Stearns. ''Just about
every company they offered it to took the deal.''
Monsanto extended its
advantage by sharing its regulatory clearances with
companies that buy the ingredient from Monsanto rather than
make it themselves. That sped up government approval ... >>
Read David BARBZA's article in the New York
Times in 2001 > Articles
on the net
EUROPE
pending
en cours
pdf 700KB
MARKETING VERT
C’est en septembre
2000 qu’AUDACE rapporte en Europe la preuve que Monsanto ...
green marketing
It is in September
2000 that AUDACE returns from the United States with the proof ...
|
A
commercial policy which consists in decreasing voluntarily the price of
the unbranded glyphosate to discourage generic producers during the period
of data protection -
Une politique commerciale qui consiste à déprécier volontairement le
prix du glyphosate sans marque afin de décourager les producteurs
génériques pendant la période de protection des données
Read the New York Times
article by
David Barboza
here below
lire l'article du New York
Times de
David Barboza
ci-dessous
—
AUDACE denounced and opposed MONSANTO’s strategy relating to the marketing
of glyphosate soon after the fall of the basic patent.
Since 2000 actions undertaken by the association before community and
national authorities aim at opposing different components of the firm’s strategy
:
1.
a commercial policy which consists in
decreasing voluntarily the price of the unbranded glyphosate to discourage
generic producers during the period of data protection >>
read more
2.
massive support for the sales of «
ROUNDUP » branded products by means of advertising campaigns but
questionable including in justice > >
to read more
3.
an antidumping duty on glyphosate
originating in the People’s Republic of China >>
MONSANTO’S COMMERCIAL STRATEGY DEFEATED ; see also
case
T-498/04
—
AUDACE dénonce et s’oppose à la stratégie de MONSANTO relative à la mise
en marché du glyphosate quelques années après la chute du brevet de base.
Depuis 2000 les actions de l’association devant les autorités
communautaires et nationales visent à combattre différents éléments de la
stratégie de la firme :
1.
une politique commerciale qui consiste à déprécier volontairement le prix
du glyphosate sans marque afin de décourager les producteurs génériques
pendant la période de protection des données
>> lire la suite
2.
le soutien aux ventes de « ROUNDUP » par des campagnes publicitaires
massives mais contestable y compris en justice
>>
lire la suite
3.
une taxe antidumping sur le glyphosate d’origine chinoise
>>
ECHEC
À LA STRATÉGIE COMMERCIALE DE MONSANTO +
lire également l'affaire T-498/04
—
|
